Spine BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Spine BioPharma's estimated annual revenue is currently $1.3M per year.
- Spine BioPharma's estimated revenue per employee is $94,107
- Spine BioPharma's total funding is $23M.
Employee Data
- Spine BioPharma has 14 Employees.
- Spine BioPharma grew their employee count by 8% last year.
Spine BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer & Chief Operating Officer | Reveal Email/Phone |
2 | VP Commercial | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP Patient Access | Reveal Email/Phone |
5 | Associate Director Operations | Reveal Email/Phone |
6 | Director, Finance & Accounting | Reveal Email/Phone |
7 | Clinical Operations Project Manager | Reveal Email/Phone |
8 | Chairman & CEO | Reveal Email/Phone |
9 | Executive Assistant To CEO | Reveal Email/Phone |
10 | Clinical Operations Associate | Reveal Email/Phone |
Spine BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 3 | 0% | N/A | N/A |
#2 | N/A | 20 | 43% | N/A | N/A |
#3 | $6.7M | 33 | -6% | N/A | N/A |
#4 | $34.4M | 222 | -1% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $10M | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $7.5M | 37 | 0% | $51.6M | N/A |
#8 | $0.3M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 21 | -16% | $3.3M | N/A |
#10 | $3.6M | 20 | 5% | N/A | N/A |
What Is Spine BioPharma?
Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction. Spine Biopharma has developed a non-surgical solution that will remove pain and restore functionality, without having to use opioids.
keywords:N/A
$23M
Total Funding
14
Number of Employees
$1.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Spine BioPharma News
U.S.-based Spine BioPharma has been given permission from the U.S. Food and Drug Administration to bypass the second phase and go directly...
Spine BioPharma specializes in non-surgical therapies that will reduce pain, restore function and slow or stop pathological spinal disease...
Spine Biopharma completed a $13 million round of Series B equity financing this week. The financing will support the development of Spine's...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 14 | 17% | $116.4M |
#2 | $0.3M | 14 | -33% | $12M |
#3 | $0.5M | 14 | -7% | $29M |
#4 | $1.8M | 14 | N/A | N/A |
#5 | $2.7M | 14 | N/A | N/A |